Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Multiple-dose Trial of Allisartan in Essential Hypertension
ChiCTR-TRC-10000884Phase 2Completed
- Sponsor
- Peking University People's Hospital
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of allisartan isoproxil in essential hypertension (4 arms), sponsored by Peking University People's Hospital. Primary endpoint: Change in seated blood pressure at Week 8 compared to baseline. Started Aug 2008; status: completed.
02
Drugs
allisartan isoproxil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR-TRC-10000884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000884.